Submissions for variant NM_001291303.3(FAT4):c.13623G>A (p.Glu4541=)

gnomAD frequency: 0.19007  dbSNP: rs62312781

Total submissions: 8

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000421361	SCV000519383	benign	not specified	2016-01-14	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp	RCV001514930	SCV001722897	benign	not provided	2024-02-01	criteria provided, single submitter	clinical testing
Genome-Nilou Lab	RCV001702771	SCV001933372	benign	Hennekam lymphangiectasia-lymphedema syndrome 2	2021-08-10	criteria provided, single submitter	clinical testing
Genome-Nilou Lab	RCV001702650	SCV001933373	benign	Van Maldergem syndrome 2	2021-08-10	criteria provided, single submitter	clinical testing
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan	RCV000421361	SCV004233527	benign	not specified	2024-01-24	criteria provided, single submitter	clinical testing	This variant is classified as Benign based on local population frequency. This variant was detected in 39% of patients studied by a panel of primary immunodeficiencies. Number of patients: 37. Only high quality variants are reported.
Breakthrough Genomics, Breakthrough Genomics	RCV001514930	SCV005303330	benign	not provided		criteria provided, single submitter	not provided
Clinical Genetics, Academic Medical Center	RCV000421361	SCV001917758	benign	not specified		no assertion criteria provided	clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	RCV000421361	SCV001969263	benign	not specified		no assertion criteria provided	clinical testing